Advanced Search

The story appears on

Page A8

March 31, 2020

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Business

Drug firm to open key digital lab

By Ding Yining | 00:00 UTC+8 March 31, 2020 | Print Edition

Boehringer Ingelheim announced yesterday that it will open a second branch of its digital lab BI X in Shanghai with an initial investment of 3 million euros (US$3.32 million).

This will be the first overseas branch for the drug firm’s digital venture outside its headquarters in Germany, and in Shanghai it aims to hire 20 new staff to develop innovative digital solutions for Chinese patients. The new branch is scheduled to open in July.

The company joins a number of multinationals that are eager to leverage the local digital landscape to forge closer ties with local startups and partners to create tailor-made solutions.

Boehringer Ingelheim’s digital lab aims to use digital innovation to accelerate the development of health-care cures and the discovery of breakthrough treatments.

Since its launch in 2017, BI X has brought together coders, data scientists, engineers and user experience designers to test and prove new applications within short time limits.

“With this step we are strengthening our footprint in a market that is very strong in digital innovation in health care and has a unique technological landscape,” said Michael Schmelmer, of Boehringer Ingelheim’s board of managing directors.

This year marks the 25th anniversary of Boehringer Ingelheim’s entry into China.

Business


 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend